In Lesotho, the pregnant women living with hiv antiretroviral therapy coverage for pmtct stands at 89%, reflecting an increase of 2% (2.3%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Lesotho
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Lesotho
PMTCT antiretroviral therapy coverage
More indicators for Lesotho
Male unintentional poisoning
6.2
-0.2
(2019)
Female wasting in children
1.7%
-1.4%
(2018)
Female prevalence of HIV
7.4%
-0.8%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar37
-intl dollar1
(2021)
Birth registration
44.5%
+1.2%
(2018)
Contraceptive modern method prevalence
64.6%
+4.8%
(2018)
Lesotho PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 89% | +2% |
| 2021 | 87% | -3% |
| 2020 | 90% | +4% |
| 2019 | 86% | -1% |
| 2018 | 87% | +10% |
| 2017 | 77% | -17% |
| 2016 | 94% | -5% |
| 2015 | 99% | +2% |
| 2014 | 97% | +7% |
| 2013 | 90% | -3% |
| 2012 | 93% | +2% |
| 2011 | 91% | +25% |
| 2010 | 66% | +13% |
| 2009 | 53% | +24% |
| 2008 | 29% | -3% |
| 2007 | 32% | +14% |
| 2006 | 18% | +12% |
| 2005 | 6% | +3% |
| 2004 | 3% | +3% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |